Due to the expression of sodium iodide symporter (NIS) and thyroid stimulating hormone (TSH)-dependent growth pattern, radioactive iodine 131 (131 I) therapy and TSH suppression therapy are effective in most differentiated thyroid cancers. Here, SLC5A5 is linked to thyroid gland carcinoma.